Bladder Cancer
Mga Pangunahing Punto
- Ang bladder cancer ang pinakakaraniwang malignancy ng urinary system.
- Ang sakit ay naiuuri bilang non-muscle invasive, muscle-invasive, o metastatic.
- Karaniwang maagang cue ang hematuria, na may posibleng frequency, urgency, dysuria, at nocturia.
- Nagsisimula ang diagnostic pathway sa cystoscopy at biopsy; sinusuportahan ng TURBT ang parehong pag-alis at staging.
- Ang management ay mula bladder-preserving intravesical therapy hanggang radical cystectomy na may urinary diversion.
Pathophysiology
Karaniwang nagsisimula ang bladder cancer sa urothelial lining. Habang lumalalim ang tumor invasion depth, malaki ang pagbabago sa treatment intensity at prognosis.
Ang non-muscle invasive disease ay maaaring manatiling localized sa superficial bladder layers, samantalang ang muscle-invasive disease ay tumatagos sa mas malalim na tissue at may mas mataas na progression risk. Ang metastatic disease ay tumutukoy sa pagkalat lampas sa bladder at nangangailangan ng systemic treatment strategies.
Classification
- Non-muscle invasive bladder cancer: Nasa mucosa/submucosa lamang; kadalasang minamanage sa local resection at intravesical therapy.
- Muscle-invasive bladder cancer: Sumasalakay sa detrusor muscle; karaniwang ginagamot sa radical cystectomy pathways.
- Metastatic bladder cancer: Kumalat na sa labas ng bladder; systemic therapy ang focus.
- Screening-evidence context: Ang routine population screening ay hindi nagpakita ng mortality benefit, kaya symptom- at risk-driven ang evaluation sa halip na universal.
Nursing Assessment
NCLEX Focus
Ang hematuria na may irritative voiding symptoms ay nangangailangan ng agarang malignancy workup kaysa watchful symptom treatment lamang.
- Suriin ang urinary cues: visible o microscopic hematuria, frequency, urgency, dysuria, at nocturia.
- I-review ang diagnostic trajectory: cystoscopy findings, biopsy confirmation, TURBT results, at staging imaging (CT/MRI/PET).
- Suriin ang treatment impact sa elimination pattern at diversion readiness kapag planado ang cystectomy.
- Suriin ang symptom burden at quality-of-life concerns kaugnay ng voiding changes at cancer diagnosis.
- Suriin ang emotional distress, altered body image/intimacy concerns (lalo na sa ostomy/diversion), at caregiver coping needs.
Nursing Interventions
- I-coordinate ang napapanahong pre/post diagnostic care para sa cystoscopy, biopsy, at TURBT.
- Palakasin ang pag-unawa sa treatment plan ayon sa stage (local intravesical approaches versus radical surgery versus systemic therapy).
- Ihanda ang clients para sa urinary diversion education kapag inaasahan ang cystectomy.
- Suportahan ang symptom management, surveillance para sa treatment adverse effects, at napapanahong escalation ng lumalalang urinary findings.
- Palakasin ang infection-sign education para sa clients na tumatanggap ng chemotherapy o surgical treatment at i-escalate agad ang concerning symptoms.
- I-coordinate ang psychosocial referrals (nurse specialist, social work/case management, support groups) kapag mataas ang coping burden.
- Hikayatin ang evidence-based coping supports (active listening, relaxation/mindfulness practice) at mag-screen para sa anxiety/depression.
- Mag-alok ng palliative-care consultation kapag mataas ang symptom burden at simulan ang advance-care-planning discussions kung naaangkop.
Post-Cystectomy Elimination Transition
Pagkatapos ng radical cystectomy, kailangang i-redirect ang daloy ng ihi; dapat i-prioritize ng nurses ang diversion education, monitoring, at complication prevention.
Pharmacology
| Drug Class | Examples | Key Nursing Considerations |
|---|---|---|
| breast-cancer-chemotherapy-safety-and-support (chemotherapy) | intravesical/systemic context | Karaniwan ang intravesical therapy pagkatapos ng TURBT sa non-muscle invasive disease. |
| immunotherapy | class-based agents | Ginagamit sa piling advanced pathways; i-monitor ang immune-related adverse effects. |
| targeted-therapy | class-based agents | Ginagamit para sa metastatic disease batay sa tumor profile at treatment response goals. |
Clinical Judgment Application
Clinical Scenario
Isang client ang may recurrent painless hematuria at urinary urgency. Nakita sa cystoscopy ang bladder lesion, at naka-schedule ang TURBT para sa pag-alis at staging.
- Recognize Cues: Hematuria kasama ang irritative urinary symptoms at cystoscopic lesion.
- Analyze Cues: Tugma ang findings sa malamang na urothelial malignancy na nangangailangan ng staging-directed treatment.
- Prioritize Hypotheses: Agarang priorities ang diagnostic completion at early treatment coordination.
- Generate Solutions: Ihanda para sa TURBT, palakasin ang education, at magplano ng post-procedure follow-up.
- Take Action: Ipatupad ang peri-procedural care at agad ipaalam ang bagong pathology/staging data.
- Evaluate Outcomes: Nasimulan ang stage-appropriate treatment at namonitor ang tugon ng urinary symptoms.
Related Concepts
- prostate-cancer - Karaniwang magkasamang tinatalakay na urinary-system malignancy na may ibang staging at treatment pathways.
- bladder-assessment - Ang hematuria at voiding-pattern analysis ang gabay sa escalation.
- postvoid-residual-measurement-and-retention-management - Kapaki-pakinabang kapag nagkaroon ng obstruction o retention habang may disease/treatment.
- benign-prostatic-hyperplasia - Mahalagang differential para sa lower urinary tract symptoms sa older adults.
- palliative-care - Sumusuporta sa symptom burden, quality of life, at goals-of-care planning sa advanced disease.
Self-Check
- Aling finding ang gumagawang prayoridad ang urgent bladder-cancer workup sa isang older adult na may urinary symptoms?
- Paano nagkakaiba ang treatment sa pagitan ng non-muscle invasive at muscle-invasive bladder cancer?
- Bakit kritikal ang maagang urinary-diversion education bago ang radical cystectomy?